SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Isotechnika
An SI Board Since August 2001
Posts SubjectMarks Bans Symbol
285 8 0 ISA
Emcee:  schzammm Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
160Isotechnika Inc. announces first quarter financial results Thursday May 13, 8:01schzammm-5/13/2004
159notyet, the number of shares does make a difference to market valuation on a prischzammm-5/13/2004
158when you ponder upside potential you should look at market cap. so with 80m sharnotyet-5/13/2004
157Comments and links from "TheArrow" on SH: stockhouse.com "Rocheteevee-5/12/2004
156>>does the number of shares concern you regarding their potential upside vIcebrg-5/10/2004
155Icebrg, I believe ISA has about diluted 80M shares outstanding. Even though theyschzammm-5/9/2004
154teevee You wrote: >>Ahhh....I am suggesting the rights to autoimmune indIcebrg-5/9/2004
153Icebrg, <i>It is difficult to have an idea about what lies behind the resteevee-5/8/2004
152Thanks for the link Icebrg and after reading the CC, I came to the same conclusischzammm-5/8/2004
151It is difficult to have an idea about what lies behind the restructuring of the Icebrg-5/8/2004
150Icebrg, I have been bothered by how one sided the renegotiated partnering deal teevee-5/8/2004
149Isotechnika Submits Clinical Trial Application to Health Canada for TAFA-93 bizschzammm-5/7/2004
148>> conference call. its archived until Friday and is a good listen. >&gIcebrg-4/26/2004
147Isotechnika Changes Roche Deal, Keeps Rights To Psoriasis Drug BioWorld Today ApIcebrg-4/22/2004
146Isotechnika Receives Approval for Multiple Dose Range Finding Study for ISA247 4teevee-4/21/2004
145check noon news release for info on conference call. its archived until Friday ateevee-4/20/2004
144Erik, I have my doubts about buying Isotechnika at this point. Maybe if as you sschzammm-4/20/2004
143So much for the 215 mUSD partnership. Evidently Roche doesn't see enough benIcebrg-4/20/2004
142Roche and Isotechnika Restructure Collaboration for the Development and CommerciIcebrg-4/20/2004
141what the heck is this about? From Sedar and Management discussion and analysis:teevee-4/2/2004
140It would have been even more interesting with some forward-looking statements. LIcebrg-3/29/2004
139Press Release Source: Isotechnika Inc. Isotechnika Inc. Announces Highlights ateevee-3/29/2004
138Isotechnika Receives Regulatory Approval in China for Helikit Friday February 27Icebrg-2/27/2004
137Isotechnika Receives Notice of Allowance for Third United States Patent PertainiIcebrg-2/26/2004
136Thanks, Eric. I'll have to read their PRs more completely. I just glanced tnsaf-2/25/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News